Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
Q3 2022 vs. Q2 2022
How the institutions holding Genmab A/S changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 181 | 2 | 194 | +15 |
| Shares | 35.6M | 2.71K | 44.4M | +8.87M (+25.0%) |
| Value | $1.15B | $88.0K | $1.43B | +$276.1M (+24.0%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Genmab A/S at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Genmab A/S at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| State Street Corp | 45,652 | $1.48M |
| Voloridge Investment Management, LLC | 45,257 | $1.47M |
| Private Advisor Group, LLC | 20,522 | $666.0K |
| Connective Portfolio Management, LLC | 18,000 | $585.0K |
| King Wealth | 16,897 | $549.0K |
| Capital Fund Management S.A. | 12,720 | $413.3K |
| Ambassador Advisors, LLC | 11,350 | $368.0K |
| Susquehanna International Group Ltd. | 10,300 | $335.0K |
| Susquehanna International Group, LLP | 8,968 | $291.0K |
| Strategic Global Advisors, LLC | 7,953 | $258.0K |
| Greenleaf Trust | 6,980 | $227.0K |
| Gyon Technologies Capital Management, LP | 6,841 | $222.0K |
| CIBC Private Wealth Group, LLC | 3,120 | $101.0K |
| Captrust Financial Advisors | 2,442 | $79.0K |
| International Biotechnology Trust PLC | 1,857 | $57.2K |
| Venture Visionary Partners LLC | 949 | $30.8K |
| Patriot Financial Group Insurance Agency, LLC | 355 | $12.0K |
| Plante Moran Financial Advisors, LLC | 151 | $5.00K |
| Albion Financial Group | 19 | $1.00K |
| Sargent Bickham Lagudis LLC | 46 | $1.00K |
| Steward Financial Group LLC | 9 | $0 |
Not filed for Q3 2022 yet (2)
Institutions that held Genmab A/S at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Private Capital Group, LLC | 2,677 | $87.0K |
| Fieldpoint Private Securities, LLC | 30 | $1.00K |